ZTI Biosciences
Suwon
About ZTI Biosciences
ZTI Biosciences develops therapeutic radiopharmaceuticals for intractable and recurring solid cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $1.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2021)
- Website: zti-bio.com
- Phone: +82 31 213 0566
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/zti-biosciences-1567 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.